Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract

Current Opinion in Virology

Volumn 2, Issue 3, 2012, Pages 233-241

  Gorski, Stacey A ^a,b   Hufford, Matthew M ^a,b   Braciale, Thomas J ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; GRANZYME; INTERFERON; INTERFERON LAMBDA; INTERLEUKIN 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; PERFORIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CELL TYPE; CONVALESCENCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; LUNG; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MACROPHAGE ACTIVATION; MEDIATOR; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY STEM CELL; RESPIRATORY FUNCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY VIRUS; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STEM CELL; T LYMPHOCYTE; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

EID: 84862897920     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.04.006     Document Type: Article

References (106)

1. Kohlmeier JE, Woodland DL: Immunity to respiratory viruses. Annu Rev Immunol 2009, 27:61-82.
2. Kumar PA, Hu Y, Yamamoto Y, Hoe NB, Wei TS, Mu D, Sun Y, Joo LS, Dagher R, Zielonka EM et al.: Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 2011, 147:525-538. This paper nicely demonstrates the existence of distal airway stem cells that can regenerate alveoli following IAV infection.
3. Roberts A, Deming D, Paddock CD, Cheng A, Yount B, Vogel L, Herman BD, Sheahan T, Heise M, Genrich GL et al.: A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog 2007, 3:e5.
4. Chen Y, Chan VS, Zheng B, Chan KY, Xu X, To LY, Huang FP, Khoo US, Lin CL: A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. J Exp Med 2007, 204:2529-2536.
5. Ling TY, Kuo MD, Li CL, Yu AL, Huang YH, Wu TJ, Lin YC, Chen SH, Yu J: Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A 2006, 103:9530-9535.
6. Nicholls JM, Butany J, Poon LL, Chan KH, Beh SL, Poutanen S, Peiris JS, Wong M: Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med 2006, 3:e27.
7. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W et al.: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005, 11:875-879.
8. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC et al.: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426:450-454.
9. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H et al.: Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005, 436:112-116.
10. Li X, Molina-Molina M, Abdul-Hafez A, Uhal V, Xaubet A, Uhal BD: Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2008, 295:L178-L185.
11. Hao X, Kim TS, Braciale TJ: Differential response of respiratory dendritic cell subsets to influenza virus infection. J Virol 2008, 82:4908-4919.
12. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A: Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A 2010, 107:11531-11536. This paper details susceptible cell types within an IAV-infected mouse lung utilizing a novel GFP reporter IAV strain.
13. Spiegel M, Schneider K, Weber F, Weidmann M, Hufert FT: Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. J Gen Virol 2006, 87:1953-1960.
14. Thitithanyanont A, Engering A, Ekchariyawat P, Wiboon-ut S, Limsalakpetch A, Yongvanitchit K, Kum-Arb U, Kanchongkittiphon W, Utaisincharoen P, Sirisinha S et al.: High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol 2007, 179:5220-5227.
15. Wang SF, Huang JC, Lee YM, Liu SJ, Chan YJ, Chau YP, Chong P, Chen YM: DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans. Biochem Biophys Res Commun 2008, 373:561-566.
16. Herold S, von Wulffen W, Steinmueller M, Pleschka S, Kuziel WA, Mack M, Srivastava M, Seeger W, Maus UA, Lohmeyer J: Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol 2006, 177:1817-1824.
17. Moltedo B, Li W, Yount JS, Moran TM: Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS Pathog 2011, 7:e1002345.
18. Kim TS, Braciale TJ: Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS ONE 2009, 4:e4204.
19. Zhao J, Zhao J, Van Rooijen N, Perlman S: Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice. PLoS Pathog 2009, 5:e1000636. This study highlights a potential mechanism for lymphopenia associated with SARS-CoV infection.
20. Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, Katsikis PD: Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. J Immunol 2011, 186:4599-4608.
21. hi cells during IAV infection drive CD8+ T lymphocyte IFNγ production in vivo in a mechanism dependent on co-stimulation.
22. Bonville CA, Bennett NJ, Koehnlein M, Haines DM, Ellis JA, DelVecchio AM, Rosenberg HF, Domachowske JB: Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology 2006, 349:87-95.
23. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN: House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009, 15:410-416.
24. Bem RA, Domachowske JB, Rosenberg HF: Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol 2011, 301:L148-L156.
25. Cleri DJ, Ricketti AJ, Vernaleo JR: Severe acute respiratory syndrome (SARS). Infect Dis Clin North Am 2010, 24:175-202.
26. Xu T, Qiao J, Zhao L, Wang G, He G, Li K, Tian Y, Gao M, Wang J, Wang H et al.: Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Crit Care Med 2006, 174:1011-1017.
27. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H: Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011, 146:980-991. This paper highlights the regulation of immune system pro-inflammatory cytokine and chemokine production during IAV infection by type I interferon and endothelial cells.
28. Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, Watanabe T, Hatta M, Shinya K, Suresh M et al.: Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A 2011, 108:12018-12023.
29. Jayasekera JP, Vinuesa CG, Karupiah G, King NJ: Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice. J Gen Virol 2006, 87:3361-3371.
30. Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD: CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 2008, 180:2562-2572. This paper nicely details macrophage cell types present in the IAV-infected lung and the role of inflammatory mononuclear cells during infection.
31. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, Mack M, Kuziel WA, Corazza N, Brunner T et al.: Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 2008, 205:3065-3077. This study demonstrates the role of TRAIL in inflammatory mononuclear cell mediated viral clearance, alveolar leakage, and enhanced mortality associated with IAV infection.
32. Aldridge JR Jr, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, Brown SA, Doherty PC, Webster RG, Thomas PG: TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A 2009, 106:5306-5311.
33. Dessing MC, van der Sluijs KF, Florquin S, van der Poll T: Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia. Clin Immunol 2007, 125:328-336.
34. Narasaraju T, Ng HH, Phoon MC, Chow VT: MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. Am J Respir Cell Mol Biol 2010, 42:732-743.
35. Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, Reading PC: Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol 2009, 183:7441-7450.
36. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM et al.: Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005, 79:14933-14944.
37. Brown DM, Dilzer AM, Meents DL, Swain SL: CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol 2006, 177:2888-2898.
38. Bem RA, van Woensel JB, Lutter R, Domachowske JB, Medema JP, Rosenberg HF, Bos AP: Granzyme A- and B-cluster deficiency delays acute lung injury in pneumovirus-infected mice. J Immunol 2010, 184:931-938.
39. Bruder D, Srikiatkhachorn A, Enelow RI: Cellular immunity and lung injury in respiratory virus infection. Viral Immunol 2006, 19:147-155.
40. La Gruta NL, Kedzierska K, Stambas J, Doherty PC: A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007, 85:85-92.
41. McGill J, Van Rooijen N, Legge KL: IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J Exp Med 2010, 207:521-534.
42. Kim TS, Sun J, Braciale TJ: T cell responses during influenza infection: getting and keeping control. Trends Immunol 2011, 32:225-231.
43. Snelgrove RJ, Godlee A, Hussell T: Airway immune homeostasis and implications for influenza-induced inflammation. Trends Immunol 2011, 32:328-334.
44. Rygiel TP, Rijkers ES, de Ruiter T, Stolte EH, van der Valk M, Rimmelzwaan GF, Boon L, van Loon AM, Coenjaerts FE, Hoek RM et al.: Lack of CD200 enhances pathological T cell responses during influenza infection. J Immunol 2009, 183:1990-1996.
45. Snelgrove RJ, Goulding J, Didierlaurent AM, Lyonga D, Vekaria S, Edwards L, Gwyer E, Sedgwick JD, Barclay AN, Hussell T: A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 2008, 9:1074-1083.
46. Zhou J, Matsuoka M, Cantor H, Homer R, Enelow RI: Cutting edge: engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia. J Immunol 2008, 180:25-29.
47. Sun J, Cardani A, Sharma AK, Laubach VE, Jack RS, Muller W, Braciale TJ: Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog 2011, 7:e1002173.
48. Sun J, Madan R, Karp CL, Braciale TJ: Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 2009, 15:277-284. The first paper to demonstrate effector T lymphocyte production of the regulatory cytokine, IL-10, during respiratory virus infection.
49. Weiss KA, Christiaansen AF, Fulton RB, Meyerholz DK, Varga SM: Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J Immunol 2011, 187:3145-3154.
50. Carlson CM, Turpin EA, Moser LA, O'Brien KB, Cline TD, Jones JC, Tumpey TM, Katz JM, Kelley LA, Gauldie J et al.: Transforming growth factor-beta: activation by neuraminidase and role inhighly pathogenic H5N1 influenza pathogenesis. PLoS Pathog 2010, 6:e1001136.
51. Williams AE, Humphreys IR, Cornere M, Edwards L, Rae A, Hussell T: TGF-beta prevents eosinophilic lung disease but impairs pathogen clearance. Microbes Infect 2005, 7:365-374.
52. Antunes I, Kassiotis G: Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice. J Virol 2010, 84:12564-12575.
53. Betts RJ, Prabhu N, Ho AW, Lew FC, Hutchinson PE, Rotzschke O, Macary PA, Kemeny DM: Influenza A virus infection results in a robust, antigen-responsive and widely disseminated Foxp3+ regulatory T cell response. J Virol 2011.
54. Fulton RB, Meyerholz DK, Varga SM: Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol 2010, 185:2382-2392.
55. Lee DC, Harker JA, Tregoning JS, Atabani SF, Johansson C, Schwarze J, Openshaw PJ: CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol 2010, 84:8790-8798.
56. Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS: Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J Virol 2009, 83:3019-3028.
57. Beers MF, Morrisey EE: The three R's of lung health and disease: repair, remodeling, and regeneration. J Clin Invest 2011, 121:2065-2073.
58. Crosby LM, Waters CM: Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010, 298:L715-L731.
59. Herard AL, Pierrot D, Hinnrasky J, Kaplan H, Sheppard D, Puchelle E, Zahm JM: Fibronectin and its alpha 5 beta 1-integrin receptor are involved in the wound-repair process of airway epithelium. Am J Physiol 1996, 271:L726-L733.
60. Roberson EC, Tully JE, Guala AS, Reiss JN, Godburn KE, Pociask DA, Alcorn JF, Riches DW, Dienz O, Janssen-Heininger YM et al.: Influenza induces ER stress, caspase-12- dependent apoptosis and JNK mediated TGF-beta release in lung epithelial cells. Am J Respir Cell Mol Biol 2011.
61. Oliver JR, Kushwah R, Wu J, Pan J, Cutz E, Yeger H, Waddell TK, Hu J: Elf3 plays a role in regulating bronchiolar epithelial repair kinetics following Clara cell-specific injury. Lab Invest 2011, 91:1514-1529.
62. Buckley S, Shi W, Barsky L, Warburton D: TGF-beta signaling promotes survival and repair in rat alveolar epithelial type 2 cells during recovery after hyperoxic injury. Am J Physiol Lung Cell Mol Physiol 2008, 294:L739-L748.
63. Rock JR, Gao X, Xue Y, Randell SH, Kong YY, Hogan BL: Notch-dependent differentiation of adult airway basal stem cells. Cell Stem Cell 2011, 8:639-648.
64. Rogel MR, Soni PN, Troken JR, Sitikov A, Trejo HE, Ridge KM: Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells. FASEB J 2011, 25:3873-3883.
65. Mebius RE, Rennert P, Weissman IL: Developing lymph nodes collect CD4+CD3-LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997, 7:493-504.
66. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa S, Gruss P: Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999, 397:702-706.
67. Fukuyama S, Hiroi T, Yokota Y, Rennert PD, Yanagita M, Kinoshita N, Terawaki S, Shikina T, Yamamoto M, Kurono Y et al.: Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(S)CD4(+)CD45(+) cells. Immunity 2002, 17:31-40.
68. Sonnenberg GF, Fouser LA, Artis D: Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011, 12:383-390.
69. Guo H, Topham DJ: Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection. J Virol 2010, 84:7750-7759.
70. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K et al.: IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008, 14:275-281.
71. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, Artis D: Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 2010, 207:1293-1305.
72. Sanos SL, Vonarbourg C, Mortha A, Diefenbach A: Control of epithelial cell function by interleukin-22-producing RORgammat+ innate lymphoid cells. Immunology 2011, 132:453-465.
73. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, Goodrich S, Woodland DL, Lund FE, Randall TD: Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004, 10:927-934.
74. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, Hartson L, Kolls JK, Khader SA, Randall TD: The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 2011, 12:639-646.
75. Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H: Human IL-25- and IL-33- responsive type2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011, 12:1055-1062.
76. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S: Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544. Elegant demonstration of the existence of natural helper cells and their production of type 2 cytokines.
77. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R et al.: Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
78. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM: Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 2010, 107:11489-11494.
79. Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban JF Jr, Tocker JE, Budelsky AL, Kleinschek MA, Kastelein RA, Kambayashi T et al.: IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, 464:1362-1366.
80. Ikutani M, Yanagibashi T, Ogasawara M, Tsuneyama K, Yamamoto S, Hattori Y, Kouro T, Itakura A, Nagai Y, Takaki S et al.: Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity. J Immunol 2012, 188:703-713.
81. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT: Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011, 12:631-638.
82. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T et al.: Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011, 12:1045-1054. First demonstration of ILC 2 producing factor other than type 2 cytokines that is important for lung homeostasis.
83. Fukumoto J, Harada C, Kawaguchi T, Suetsugu S, Maeyama T, Inoshima I, Hamada N, Kuwano K, Nakanishi Y: Amphiregulin attenuates bleomycin-induced pneumopathy in mice. Am J Physiol Lung Cell Mol Physiol 2010, 298:L131-L138.
84. Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K, Sparwasser T, Helmby H, Stockinger B: An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 2011, 12:1071-1077.
85. Singhera GK, MacRedmond R, Dorscheid DR: Interleukin-9 and - 13 inhibit spontaneous and corticosteroid induced apoptosis of normal airway epithelial cells. Exp Lung Res 2008, 34:579-598.
86. Le Goffic R, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, Piquet-Pellorce C, Samson M: Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol 2011, 45:1125-1132.
87. Kaiko GE, Phipps S, Angkasekwinai P, Dong C, Foster PS: NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J Immunol 2010, 185:4681-4690.
88. Allen JE, Wynn TA: Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 2011, 7:e1002003.
89. Chen F, Liu Z, Wu W, Rozo C, Bowdridge S, Millman A, Van Rooijen N, Urban JF Jr, Wynn TA, Gause WC: An essential role for T(H)2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med 2012, 18:260-266.
90. Loke P, Gallagher I, Nair MG, Zang X, Brombacher F, Mohrs M, Allison JP, Allen JE: Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J Immunol 2007, 179:3926-3936.
91. Gordon S, Martinez FO: Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
92. Varin A, Gordon S: Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009, 214:630-641.
93. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA: Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 2001, 167:6533-6544.
94. Gibbons MA, MacKinnon AC, Ramachandran P, Dhaliwal K, Duffin R, Phythian-Adams AT, van Rooijen N, Haslett C, Howie SE, Simpson AJ et al.: Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med 2011, 184:569-581.
95. Shirey KA, Pletneva LM, Puche AC, Keegan AD, Prince GA, Blanco JC, Vogel SN: Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol 2010, 3:291-300. Alternatively activated macrophages limit tissue damage during RSV infection of mice.
96. Senft AP, Taylor RH, Lei W, Campbell SA, Tipper JL, Martinez MJ, Witt TL, Clay CC, Harrod KS: Respiratory syncytial virus impairs macrophage IFN-alpha/beta- and IFN-gamma-stimulated transcription by distinct mechanisms. Am J Respir Cell Mol Biol 2010, 42:404-414.
97. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T: Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121:823-835.
98. Teisanu RM, Lagasse E, Whitesides JF, Stripp BR: Prospective isolation of bronchiolar stem cells based upon immunophenotypic and autofluorescence characteristics. Stem Cells 2009, 27:612-622.
99. McQualter JL, Brouard N, Williams B, Baird BN, Sims-Lucas S, Yuen K, Nilsson SK, Simmons PJ, Bertoncello I: Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 2009, 27:623-633.
100. Nolen-Walston RD, Kim CF, Mazan MR, Ingenito EP, Gruntman AM, Tsai L, Boston R, Woolfenden AE, Jacks T, Hoffman AM: Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am J Physiol Lung Cell Mol Physiol 2008, 294:L1158-L1165.
101. Rawlins EL, Okubo T, Xue Y, Brass DM, Auten RL, Hasegawa H, Wang F, Hogan BL: The role of Scgb1a1+ Clara cells in the longterm maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 2009, 4:525-534.
102. Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, Randell SH, Hogan BL: Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci U S A 2009, 106:12771-12775.
103. Mallick B, Ghosh Z, Chakrabarti J: MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells. PLoS ONE 2009, 4:e7837.
104. Daniely Y, Liao G, Dixon D, Linnoila RI, Lori A, Randell SH, Oren M, Jetten AM: Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium. Am J Physiol Cell Physiol 2004, 287:C171-C181.
105. Senoo M, Pinto F, Crum CP, McKeon F: p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007, 129:523-536.
106. Kash JC, Walters KA, Davis AS, Sandouk A, Schwartzman LM, Jagger BW, Chertow DS, Li Q, Kuestner RE, Ozinsky A et al.: Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. mBio 2011:2.